Projects funded by the NCN
Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment
2025/56/C/NZ6/00491
Keywords:
Exosome therapy NK cells extracellular vesicles targeted cancer treatment exosome engineering cancer immunotherapy
Descriptors:
- NZ6_11:
- NZ7_05:
- NZ6_03:
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk
woj. dolnośląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: SONATINA 9 - announced on 2024-12-16
Amount awarded: 1 889 302 PLN
Project start date (Y-m-d): 2025-09-12
Project end date (Y-m-d): 2028-09-11
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.